Introduction
============

The soluble form of the receptor for advanced glycation endproducts (sRAGE) is a promising marker for epithelial dysfunction, but it has not been fully characterized as a biomarker during ARDS. Whether sRAGE could inform on the response to ventilator settings has been poorly investigated, and whether recruitment maneuver (RM) may influence plasma sRAGE remains unknown.

Methods
=======

Twenty-four patients with moderate/severe, nonfocal ARDS were enrolled in this prospective monocentric crossover study and randomized into a \'RM-SHAM\' group when a 6-hour-long RM sequence preceded a 6-hour-long sham evaluation period, or a \'SHAM-RM\' group (inverted sequences). Protective ventilation was applied, and RM consisted of the application of 40 cmH~2~O airway pressure for 40 seconds. Arterial blood was sampled for gas analyses and sRAGE measurements, 5 minutes pre RM (or 40-second-long sham period), 5 minutes, 30 minutes, 1 hour, 4 hours and 6 hours after the RM (or 40-second-long sham period).

Results
=======

Mean PaO~2~/FiO~2~, tidal volume, PEEP and plateau pressure were 125 mmHg, 6.8 ml/kg (ideal body weight), 13 and 26 cmH~2~O, respectively. Median baseline plasma sRAGE levels were 3,232 pg/ml. RM induced a significant decrease in sRAGE (-1,598 ± 859 pg/ml) in 1 hour (*P*= 0.043). At 4 and 6 hours post RM, sRAGE levels increased back toward baseline values. Pre-RM sRAGE was associated with RM-induced oxygenation improvement (AUC 0.87). See Figure [1](#F1){ref-type="fig"}.
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Conclusion
==========

We report the first kinetics study of plasma sRAGE after RM in ARDS. Our findings could help to design future studies of sRAGE as a marker of response to therapeutic interventions during ARDS.
